Autocrine IL-2-dependent growth of a newly established CD3+, CD16-, CD56+, CD57+, J(H)-, TCRbeta-, TCRgamma- leukemia cell line (NOI-90). [electronic resource]
Producer: 19970224Description: 245-52 p. digitalISSN:- 0887-6924
- CD3 Complex -- analysis
- CD56 Antigen -- analysis
- CD57 Antigens -- analysis
- Culture Media, Conditioned -- pharmacology
- Embryonal Carcinoma Stem Cells
- Fatal Outcome
- Fluorescent Antibody Technique, Indirect
- Gene Rearrangement
- Humans
- Immunoglobulin Heavy Chains -- analysis
- Immunophenotyping
- Interleukin-2 -- pharmacology
- Male
- Middle Aged
- Neoplastic Stem Cells -- drug effects
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- pathology
- Receptors, Antigen, T-Cell, alpha-beta -- analysis
- Receptors, Antigen, T-Cell, gamma-delta -- analysis
- Receptors, IgG -- analysis
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Case Reports; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.